BioAffinity Technologies Correlations
| BIAFW Stock | USD 0.24 0.02 9.09% |
The current 90-days correlation between BioAffinity Technologies and bioAffinity Technologies, is -0.02 (i.e., Good diversification). The correlation of BioAffinity Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
BioAffinity Technologies Correlation With Market
Significant diversification
The correlation between bioAffinity Technologies Warra and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and DJI in the same portfolio, assuming nothing else is changed.
BioAffinity |
Moving together with BioAffinity Stock
Moving against BioAffinity Stock
| 0.44 | PLX | Protalix Biotherapeutics | PairCorr |
| 0.37 | GE | GE Aerospace | PairCorr |
| 0.33 | LUCD | Lucid Diagnostics | PairCorr |
| 0.75 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.72 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.46 | MMM | 3M Company | PairCorr |
| 0.32 | INTC | Intel | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BioAffinity Stock performing well and BioAffinity Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioAffinity Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BIAF | 4.94 | (1.63) | 0.00 | (0.77) | 0.00 | 11.27 | 38.76 | |||
| AAPJ | 22.77 | 6.34 | 0.11 | 1.11 | 18.57 | 100.00 | 150.00 | |||
| DPUI | 14.51 | 3.61 | 0.07 | 2.28 | 14.27 | 100.00 | 150.00 | |||
| CDSG | 16.41 | 2.75 | 0.16 | (1.92) | 15.00 | 30.77 | 185.29 | |||
| PKBO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
BioAffinity Technologies Corporate Management
| Timothy JD | Secretary VP | Profile | |
| Dallas Coleman | National Sales | Profile | |
| William Bauta | Senior Therapeutics | Profile | |
| Maria JD | President, Founder | Profile | |
| Xavier MS | VP Operations | Profile |